1191 related articles for article (PubMed ID: 28803030)
1. Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial.
Schönenberg M; Wiedemann E; Schneidt A; Scheeff J; Logemann A; Keune PM; Hautzinger M
Lancet Psychiatry; 2017 Sep; 4(9):673-684. PubMed ID: 28803030
[TBL] [Abstract][Full Text] [Related]
2. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
[TBL] [Abstract][Full Text] [Related]
3. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder.
van Dongen-Boomsma M; Vollebregt MA; Slaats-Willemse D; Buitelaar JK
J Clin Psychiatry; 2013 Aug; 74(8):821-7. PubMed ID: 24021501
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Adolesc Psychopharmacol; 2016 May; 26(4):344-53. PubMed ID: 26771913
[TBL] [Abstract][Full Text] [Related]
5. Learning curves of theta/beta neurofeedback in children with ADHD.
Janssen TWP; Bink M; Weeda WD; Geladé K; van Mourik R; Maras A; Oosterlaan J
Eur Child Adolesc Psychiatry; 2017 May; 26(5):573-582. PubMed ID: 27866283
[TBL] [Abstract][Full Text] [Related]
6. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
Geladé K; Janssen TW; Bink M; van Mourik R; Maras A; Oosterlaan J
J Clin Psychiatry; 2016 Oct; 77(10):e1270-e1277. PubMed ID: 27631143
[TBL] [Abstract][Full Text] [Related]
7. EEG Neurofeedback Training in Children With Attention Deficit/Hyperactivity Disorder: A Cognitive and Behavioral Outcome Study.
Shereena EA; Gupta RK; Bennett CN; Sagar KJV; Rajeswaran J
Clin EEG Neurosci; 2019 Jul; 50(4):242-255. PubMed ID: 30453757
[TBL] [Abstract][Full Text] [Related]
8. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
9. Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Vidal R; Castells J; Richarte V; Palomar G; García M; Nicolau R; Lazaro L; Casas M; Ramos-Quiroga JA
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):275-82. PubMed ID: 25791144
[TBL] [Abstract][Full Text] [Related]
10. NIRS-based neurofeedback training in a virtual reality classroom for children with attention-deficit/hyperactivity disorder: study protocol for a randomized controlled trial.
Blume F; Hudak J; Dresler T; Ehlis AC; Kühnhausen J; Renner TJ; Gawrilow C
Trials; 2017 Jan; 18(1):41. PubMed ID: 28118856
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
12. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of methylphenidate and behavioural parent training for children aged 3-5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial.
Sugaya LS; Salum GA; de Sousa Gurgel W; de Morais EM; Del Prette G; Pilatti CD; Dalmaso BB; Leibenluft E; Rohde LA; Polanczyk GV
Lancet Child Adolesc Health; 2022 Dec; 6(12):845-856. PubMed ID: 36306807
[TBL] [Abstract][Full Text] [Related]
14. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
[TBL] [Abstract][Full Text] [Related]
15. Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.
Geissler J; Jans T; Banaschewski T; Becker K; Renner T; Brandeis D; Döpfner M; Dose C; Hautmann C; Holtmann M; Jenkner C; Millenet S; Romanos M
Trials; 2018 Apr; 19(1):254. PubMed ID: 29703226
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.
Sudnawa KK; Chirdkiatgumchai V; Ruangdaraganon N; Khongkhatithum C; Udomsubpayakul U; Jirayucharoensak S; Israsena P
Pediatr Int; 2018 Sep; 60(9):828-834. PubMed ID: 29931709
[TBL] [Abstract][Full Text] [Related]
17. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Philipsen A; Jans T; Graf E; Matthies S; Borel P; Colla M; Gentschow L; Langner D; Jacob C; Groß-Lesch S; Sobanski E; Alm B; Schumacher-Stien M; Roesler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Heinrich V; Huss M; Kornmann C; Bürger A; Perlov E; Ihorst G; Schlander M; Berger M; Tebartz van Elst L;
JAMA Psychiatry; 2015 Dec; 72(12):1199-210. PubMed ID: 26536057
[TBL] [Abstract][Full Text] [Related]
18. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up.
Meisel V; Servera M; Garcia-Banda G; Cardo E; Moreno I
Biol Psychol; 2013 Sep; 94(1):12-21. PubMed ID: 23665196
[TBL] [Abstract][Full Text] [Related]
19. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial.
Pelsser LM; Frankena K; Toorman J; Savelkoul HF; Dubois AE; Pereira RR; Haagen TA; Rommelse NN; Buitelaar JK
Lancet; 2011 Feb; 377(9764):494-503. PubMed ID: 21296237
[TBL] [Abstract][Full Text] [Related]
20. Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial.
Aggensteiner PM; Brandeis D; Millenet S; Hohmann S; Ruckes C; Beuth S; Albrecht B; Schmitt G; Schermuly S; Wörz S; Gevensleben H; Freitag CM; Banaschewski T; Rothenberger A; Strehl U; Holtmann M
Eur Child Adolesc Psychiatry; 2019 Aug; 28(8):1087-1095. PubMed ID: 30610380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
